Anti-rheumatic activity of chloroquine-SLN gel on wistar rats using complete freund's adjuvant (CFA) model

Indian Journal of Rheumatology

Volumn 10, Issue 2, 2015, Pages 58-64

  Bhalekar, Mangesh R ^a   Upadhaya, Prashant G ^a   Nalawade, Sandip D ^a   Madgulkar, Ashwini R ^a   Kshirsagar, Sanjay J ^a  

^a AISSMS COLLEGE OF PHARMACY   (India)

Author keywords

CFA (Complete Freund's adjuvant); Chloroquine; DMARD (Disease modifying anti rheumatic drug); Rheumatoid arthritis (RA); SLN (Solid lipid nanoparticles)

Indexed keywords

CHLOROQUINE; FREUND ADJUVANT; GLYCEROL BEHENATE; SOLID LIPID NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE EROSION; CARTILAGE DEGENERATION; CONTROLLED STUDY; DRUG FORMULATION; EX VIVO STUDY; GEL; HISTOPATHOLOGY; MALE; NONHUMAN; PARTICLE SIZE; PAW EDEMA; PHARMACODYNAMICS; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS; SCANNING ELECTRON MICROSCOPY; ULTRASOUND; VISCOSITY;

EID: 84991839980     PISSN: 09733698     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.injr.2015.03.008     Document Type: Article

References (24)

1. S. Sweeney, and G. Firestein Rheumatoid arthritis: regulation of synovial inflammation Int J BioChem Cell Biol 36 2004 372 378
2. C. Jang, J. Choi, M. Byun, and D. Jue Chloroquine inhibits production of TNF α, IL-1β and IL-6 from lipopolysaccharide- stimulated human monocytes/macrophages by different modes Rheumatology 45 2006 703 710
3. P. Singh, and M. Robert Skin permeability and local tissue concentration of non-steroidal anti-inflammatory drugs after topical application J Pharmcol Exp Ther 268 1994 144 151
4. V. Majithia, and S. Geraci Rheumatoid arthritis: diagnosis and management Am J Med 120 2007 936 939
5. T. Pincus, L.F. Callahan, and V.G. Sale Severe functional declines, work disability, and increased mortality in seventy five rheumatoid arthritis patients studied over nine years Arthritis Rheum 27 1984 864 872
6. M. Harsh Textbook of Pathology 3rd ed. 1998 Jaypee Brothers Medical Publishers New Delhi 199
7. W.A. Neill, G.S. Panayi, and J.J.R. Duthie Action of chloroquine phosphate in rheumatoid arthritis Ann Rheum Dis 32 1973 547 554
8. Olajire A. Adegoke, Chinedum P. Babalola, Oluwaseun S. Oshitade, and Abiola, A. Famuyiwa Determination of the physicochemical properties of pyronaridine - A new antimalarial drug Pak J Pharm Sci 19 2006 1 6
9. R.H. Müller, K. Mäder, and S. Gohla Solid lipid nanoparticles (SLN) for controlled drug delivery - A review of the state of art Eur J Pharm Biopharm 50 2000 161 177
10. R.H. Müller, M. Radtke, and S.A. Wissing Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations Adv Drug Deliv Rev 54 2002 S131 S155
11. M.K. Das, and A.B. Ahmed Formulation and evaluation of rofecoxib gel for topical application Acta Pol Pharm 63 2007 461 467
12. S.J. Carter Cooper and Gunn's Dispersing of Pharmaceutical Students 12th ed. 2000 CBS Publishers and Distributors Delhi 192 199
13. Guidance for industry nonsterile semisolid dosage forms. Scale-Up and Postapproval Changes (SUPAC): Chemistry, manufacturing, and controls; in -Vitro release testing and in- Vivo bioequivalence documentation.
14. A report by Dr Walter Diembeck. Head of In Vitro Biocompatibility/Screening Department, BDF Beiersdorf AG. 'Using in vitro skin absorption and penetration testing as an alternative to animal testing'.
15. B.B. Newbould Chemotherapy of arthritis induced in rats by injection of mycobacterial adjuvant Br J Pharmacol Chemother 21 1963 127 137
16. V.L. Kumar, S. Roy, R. Sehgal, and B.M. Padhy A comparative study on the efficacy of rofecoxib in monoarticular arthritis induced by latex of Calotropis procera and Freund's complete adjuvant Inflammopharmacology 14 2006 17 21
17. B. Singh, S. Bani, D.K. Gupta, B.K. Chandan, and A. Kaul Anti-inflammatory activity of 'TAF' an active fraction from the plant Barleria prionitis Linn J Ethnopharmacol 85 2003 187 193
18. Y. Yu, Z. Xiong, Y. Lv, Y. Qian, S. Jiang, and Y. Tian In vivo evaluation of early disease progression by X - ray phase-contrast imaging in the adjuvant-induced arthritic rat Skelet Radiol 35 2006 156 164
19. X. Cai, Y.F. Wong, and H. Zhou The comparative study of Sprague-Dawley and Lewis rats in adjuvant- induced arthritis Naunyn-Schmiedeberg's Arch Pharmacol 373 2006 140 147
20. J.R. Ward, and R.S. Cloud Comparative effect of antirheumatic drugs on adjuvant-induced polyarthritis in rats J Pharmacol Exp Ther 152 1966 116 121
21. S.M. Mali, A. Sinnathambi, S.L. Bodhankar, and K.R. Mahadik Antiarthritic activity of standardised extract of phyllanthus amarus in Freund's complete adjuvant induced arthritis Biomed Aging Pathol. 1 2011 185 190
22. U.A. Shinde, A.S. Phadake, A.M. Nair, A.A. Mungantiwar, V.J. Dishit, and M.N. Saraf Studies on the anti-inflammatory and analgesic activity of Cedrus deodara (Roxb.) Loud. wood oil J Ethnopharmacol 65 1999 21 27
23. J. Hadgraft Passive enhancement strategies in topical and transdermal drug delivery Int J Pharm 184 1999 1 6
24. C.H. Jang Chloroquine inhibits production of TNF-a, IL-1b and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes Rheumatology 45 2006 703 710